The US Food and Drug Administration (FDA) announced today it had scheduled a meeting of the Center for Biologics Evaluation and Research (CBER) to convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
During this meeting on June 10, 2021, the FDA will provide a status update on its approach to Emergency Use Authorization (EUA) for COVID-19 vaccines intended for use in individuals 12 through 17 years of age.
Read More
